Validation of Actigraph Measured Sleep During Acute Diverticulitis

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to investigate the accuracy of actigraph measured sleep compared to the golden standard (polysomnography) during Acute uncomplicated diverticulitis. Our hypothesis is the actigraph is accurate for sleep-monitoring for this group of patients

Detailed Description
-----------------
The actigraph has been proven to measured sleep data with an accuracy about 80% (compared with Polysomnography) in patients who have undergone surgery. But this accuracy has not been validated in relation to none surgical inflammatory diseases. This study will investigate the accuracy of actigraph measured sleep in diverticulitis patients. Following methods will be applied Device: Wrist-Actigraph - Octagonal Basic Motionlogger, Ambulatory monitoring Inc, New York, USA Other: Sleep-diary Device: Polysomnograph - Embla Titanium (Natus Medical Incorporated, USA)

Official Title
-----------------
Accuracy of Actigraph Measured Sleep Compared to Polysomnography During Acute Uncomplicated Diverticulitis

Conditions
-----------------
Acute Diverticulitis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: CT-verified diverticulitis patients managed by antibiotic treatment at Herlev Hospital Pain and fever occurred less than 72 hours prior to the admission ASA (American Society of Anesthesiologists) score I to III Exclusion Criteria: Surgical intervention needed Complicated diverticulitis Complications in relation to diverticulitis Pain and fever occurred more than 72 hours prior to the admission In anticoagulant treatment and heart rate control treatment Known Autoimmune disease Known medically treated sleep-disorder (insomnia, restless legs etc.) and sleep apnea Shift-work or jetlag Daily use of opioid, psychopharmaca, opioids or anxiolytics (including Hypnotics) Known psychiatry conditions in treatment with psychopharmaca Daily alcohol intake of more than 5 units or drug abuse Missing written consent Diabetes Mellitus Predicted bad compliance Pregnant or breast-feeding Urine or fecal incontinence Severe kidney disease Current cancer

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Acute Diverticulitis<br>CT-verified acute uncomplicated diverticulitis managed by antibiotics | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in Sleep data during acute uncomplicated diverticulitis (1-5th days following the admission) from baseline at remission (5th-30th days) | Sleep measured by Actigraphy (total minutes asleep, sleep effectiveness, sleep latency, awakenings). A wrist actigraph wil be worn from 1st day of the admission and taken off on the 31st day. | 1st-30th days following the admission | 
| Changes in Circadian rhythm during acute uncomplicated diverticulitis (1-5th days following the admission) from baseline at remission (5th-30th days) | Circadian rhythm measured by Actigraphy. A wrist actigraph wil be worn from 1st day of the admission and taken off on the 31st day. | 1st-30th days following the admission | 
| Accuracy of actigraphy measured sleep data in compare to Polysomnography both in inflammatory condition and in remission condition | Sleep data measured by Actigraphy (total minutes asleep, sleep effectiveness, sleep latency, awakenings) are to validate with the PSG-measured data | 1st, 2nd and 30th days following the admission |